Literature DB >> 12817809

YM-254890, a novel platelet aggregation inhibitor produced by Chromobacterium sp. QS3666.

Masatoshi Taniguchi1, Koji Nagai, Nakako Arao, Tomihisa Kawasaki, Tetsu Saito, Yumiko Moritani, Jun Takasaki, Kazumi Hayashi, Shigeo Fujita, Ken-ichi Suzuki, Shin-ichi Tsukamoto.   

Abstract

A novel platelet aggregation inhibitor, YM-254890, was isolated from the culture broth of strain QS3666. This strain was isolated from a soil sample collected at Okutama, Tokyo, Japan, and was identified as Chromobacterium sp. by morphological and physiological criteria. YM-254890 was purified from the culture supernatant by solvent extraction, ODS and silica gel flash chromatography, followed by preparative HPLC. YM-254890 inhibited ADP-induced platelet aggregation in human platelet-rich plasma with an IC50 value below 0.6 microM by blocking the P2Y1 receptor-signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12817809     DOI: 10.7164/antibiotics.56.358

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  35 in total

Review 1.  Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Michihiro Ohno; Bhalchandra V Joshi; Pedro Besada; Bin Xu; Susanna Tchilibon
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

2.  Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule.

Authors:  Akiyuki Nishimura; Ken Kitano; Jun Takasaki; Masatoshi Taniguchi; Norikazu Mizuno; Kenji Tago; Toshio Hakoshima; Hiroshi Itoh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-16       Impact factor: 11.205

3.  Inhibition of heterotrimeric G protein signaling by a small molecule acting on Galpha subunit.

Authors:  Mohammed Akli Ayoub; Marjorie Damian; Christian Gespach; Eric Ferrandis; Olivier Lavergne; Olivier De Wever; Jean-Louis Banères; Jean-Philippe Pin; Grégoire Pierre Prévost
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

Review 4.  Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.

Authors:  Adam J Kimple; Dustin E Bosch; Patrick M Giguère; David P Siderovski
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

Review 5.  Gaq proteins: molecular pharmacology and therapeutic potential.

Authors:  Danielle Kamato; Partha Mitra; Felicity Davis; Narin Osman; Rebecca Chaplin; Peter J Cabot; Rizwana Afroz; Walter Thomas; Wenhua Zheng; Harveen Kaur; Margaret Brimble; Peter J Little
Journal:  Cell Mol Life Sci       Date:  2016-11-04       Impact factor: 9.261

6.  Potent and Selective Peptide-based Inhibition of the G Protein Gαq.

Authors:  Thomas H Charpentier; Gary L Waldo; Emily G Lowery-Gionta; Krzysztof Krajewski; Brian D Strahl; Thomas L Kash; T Kendall Harden; John Sondek
Journal:  J Biol Chem       Date:  2016-10-14       Impact factor: 5.157

7.  Differential phosphorylation of myosin light chain (Thr)18 and (Ser)19 and functional implications in platelets.

Authors:  T M Getz; C A Dangelmaier; J Jin; J L Daniel; S P Kunapuli
Journal:  J Thromb Haemost       Date:  2010-10       Impact factor: 5.824

Review 8.  Targeting G protein-coupled receptor signalling by blocking G proteins.

Authors:  Adrian P Campbell; Alan V Smrcka
Journal:  Nat Rev Drug Discov       Date:  2018-09-28       Impact factor: 84.694

9.  RhoA downstream of G(q) and G(12/13) pathways regulates protease-activated receptor-mediated dense granule release in platelets.

Authors:  Jianguo Jin; Yingying Mao; Dafydd Thomas; Soochong Kim; James L Daniel; Satya P Kunapuli
Journal:  Biochem Pharmacol       Date:  2008-11-25       Impact factor: 5.858

10.  On the selectivity of the Gαq inhibitor UBO-QIC: A comparison with the Gαi inhibitor pertussis toxin.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2016-03-05       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.